Postexercise Hypotension and Exercise Adherence
Using the Immediate Blood Pressure Benefits of Exercise to Improve Exercise Adherence Among Adults With Hypertension
1 other identifier
interventional
24
0 countries
N/A
Brief Summary
Sedentary (n=24) adults ≥18 yr with elevated BP to established hypertension were enrolled into this randomized clinical trial entitled, 'Blood Pressure UtiLizing Self-Monitoring after Exercise study or PULSE'. Participants were randomly assigned to either an exercise only (EXERCISE; n=12) or exercise plus BP self-monitoring (EXERCISE+PEH) (n=12) group. All participants participated in a 12 wk supervised moderate intensity aerobic exercise training program 40 min/d for 3 d/wk. In addition, they were encouraged to exercise at home ≥30 min/d for 1-2 d/wk. All participants self-monitored exercise with a traditional calendar recording method and heart rate (HR) monitor. In addition to traditional exercise self-monitoring (EXERCISE), individuals in the EXERCISE+PEH group were given a home BP monitor to assess home BP twice daily (in the morning upon awakening and in the evening) and prior to and after voluntary home exercise sessions. Resting BP, peak oxygen consumption (VO2peak), physical activity, dietary and salt intake, and antihypertensive medication adherence were measured before and after the 12 wk supervised exercise training program. In addition, integrated social-cognitive predictors of exercise that included questionnaires on exercise self-efficacy, barriers self-efficacy, outcome expectations for exercise, exercise intention, and affective responses to exercise were measured before and after the 12 wk supervised exercise training program. Four weeks following the completion of exercise training, self-reported exercise levels were assessed during a telephone interview in both groups. Among EXERCISE+PEH only, self-monitoring of BP was also self-reported during this telephone interview.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started Oct 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 28, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 29, 2018
CompletedFirst Submitted
Initial submission to the registry
December 11, 2018
CompletedFirst Posted
Study publicly available on registry
December 19, 2018
CompletedMay 13, 2024
May 1, 2024
1.5 years
December 11, 2018
May 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Exercise Adherence
Exercise adherence to the 12 wk supervised portion of the aerobic exercise training program was calculated as the percent of supervised exercise sessions completed divided by the total number of supervised sessions possible (# of supervised sessions performed ÷ total number of possible supervised sessions X 100%). In this calculation, the total number of possible sessions was calculated as: 3 supervised exercise training days per wk for 12 wk = 36 sessions with a maximum possible adherence of 100% (e.g., 36÷36 X 100% =100%).
12 weeks
Blood Pressure Response to Exercise Training
The BP response to aerobic exercise training was calculated in two ways and in units 'mmHg': (1) in the laboratory (post training resting BP - pre training resting BP) during the control visits (Visits 1 or 2 vs. Visit 4 or 5); and (2) under ambulatory conditions (post training ambulatory BP - pre training ambulatory BP) following the control visits (Visits 1 or 2 vs. Visit 4 or 5) over the awake, sleep, and 19 hr.
12 weeks
Blood Pressure Response to Each Exercise Training Session
In the sub study analysis, the difference in post- minus pre-exercise resting BP from three weekly exercise sessions per participant for each week of training was calculated for both SBP and DBP (in units of 'mmHg')
12 weeks
Relative Change in Blood Pressure From Baseline for Each Exercise Session
The relative percent change in BP for each exercise session was calculated as post- minus pre-exercise BP divided by pre-exercise BP x 100%, for each exercise training session for both SBP and DBP. A negative percent change in SBP and/or DBP from baseline was deemed that postexercise hypotension occurred.
12 weeks
Reliability of Postexercise Hypotension
To quantify the reliability of postexercise hypotension, RMANCOVA and GRMANCOVA adjusted for pre-exercise BP derived the between-participant and measurement error variability that were used to calculate the intraclass correlation coefficient (unit-less)
12 weeks
Time Course of Change in the Magnitude of Postexercise Hypotension
The Akaike Information Criterion (unit-less) was calculated to compare the goodness-of-fit of the postexercise hypotension models for each week of training and to determine the week of exercise training after which the the magnitude of reductions in SBP and DBP ceased to differ week-to-week.
12 wk
Secondary Outcomes (9)
Exercise Training Characteristics: Frequency
12 weeks
Exercise Training Characteristics: Intensity
12 weeks
Exercise Training Characteristics: Time
12 weeks
Exercise Training Characteristics: Type
12 weeks
Integrated social-cognitive predictor of exercise
12 weeks
- +4 more secondary outcomes
Study Arms (2)
EXERCISE
ACTIVE COMPARATORParticipants participated in a the exercise training program and engaged in exercise self-monitoring.
EXERCISE+PEH
EXPERIMENTALParticipants participated in the exercise training program and engaged in exercise self-monitoring and blood pressure self-monitoring (daily and before and after exercise).
Interventions
Participants engaged in exercise self-monitoring utilizing a traditional calendar recording method and heart rate monitor.
Participants engaged in blood pressure self-monitoring by measuring blood pressure twice daily and before and after exercise.
Eligibility Criteria
You may qualify if:
- ≥18 yr
- SBP ≥130 mmHg or DBP ≥80 mmHg or taking antihypertensive medication regardless of BP with a SBP \<160 mmHg and DBP \<100 mmHg
- Free of diagnosed cardiovascular, pulmonary, renal, metabolic, or other chronic diseases or depression
- Non-smokers for at least 6 mo prior to entry
- Consumed \<2 alcoholic drinks daily
- Physically inactive defined as engaging in formal exercise ≤ 2d/wk.
You may not qualify if:
- Taking medications that influenced blood pressure such as inhaled or oral steroids, nonsteroidal anti-inflammatory agents, aspirin, and nutritional supplements with the exception of a 1-a-day vitamin, cold medications, and herbal supplements
- Osteoarthritis and orthopedic problems that compromised ability to exercise.
- Past medical history of cancer-related lymphedema
- Seeking to gain or lose weight
- Pregnant, lactating, or planning to become pregnant.
- Hormone-altering contraception administered in a bolus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Connecticutlead
- Hartford Hospitalcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Linda S Pescatello, PhD
University of Connecticut
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Board of Trustees Distinguished Professor
Study Record Dates
First Submitted
December 11, 2018
First Posted
December 19, 2018
Study Start
October 28, 2016
Primary Completion
May 1, 2018
Study Completion
May 29, 2018
Last Updated
May 13, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- All IPD data will be available upon request with no time limit.
- Access Criteria
- All IPD data will be shared and emailed to whoever requests it.
All IPD data will be made available upon request.